Earnings Outlook For Plus Therapeutics
Portfolio Pulse from Benzinga Insights
Plus Therapeutics (NASDAQ:PSTV) is set to release its latest quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $-1.12. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price. The stock is currently trading at $1.07, down 84.4% over the last 52-week period.
October 30, 2023 | 9:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Plus Therapeutics is expected to report an EPS of $-1.12. Despite beating EPS estimates in the past, the company's share price has typically dropped. The stock is down 84.4% over the last year.
The company has a history of beating EPS estimates but this has not translated into a rise in share price. Given the stock's poor performance over the past year, investors are likely to be bearish going into this earnings release.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100